Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Anemia

Free Subscription Articles published in Leukemia Retrieve available abstracts of 22 articles: HTML format

Single Articles

February 2023
1. HUBER S, Haferlach T, Meggendorfer M, Hutter S, et al
   Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts.
   Leukemia. 2023;37:500-502.
   PubMed    
   
   
   October 2022
2. PAGLIUCA S, Gurnari C, Hercus C, Hergalant S, et al
   Molecular landscape of immune pressure and escape in aplastic anemia.
   Leukemia. 2022 Oct 17. pii: 10.1038/s41375-022-01723.
   PubMed     Abstract available
   
   
   September 2022
3. MESA R, Harrison C, Oh ST, Gerds AT, et al
   Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis.
   Leukemia. 2022;36:2261-2268.
   PubMed     Abstract available
   
   
   August 2022
4. KELKKA T, Tyster M, Lundgren S, Feng X, et al
   Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia.
   Leukemia. 2022 Aug 5. pii: 10.1038/s41375-022-01654.
   PubMed     Abstract available
   
   
   July 2022
5. GROARKE EM, Patel BA, Shalhoub R, Gutierrez-Rodrigues F, et al
   Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.
   Leukemia. 2022 Jul 27. pii: 10.1038/s41375-022-01636.
   PubMed     Abstract available
   
   
   May 2022
6. HUANG Y, Chen M, Yang C, Ruan J, et al
   Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.
   Leukemia. 2022;36:1351-1360.
   PubMed     Abstract available
   
   
   
7. KOMROKJI RS, Platzbecker U, Fenaux P, Zeidan AM, et al
   Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
   Leukemia. 2022;36:1432-1435.
   PubMed    
   
   
   April 2022
8. TSUJI N, Hosokawa K, Urushihara R, Tanabe M, et al
   Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
   Leukemia. 2022 Apr 26. pii: 10.1038/s41375-022-01549.
   PubMed     Abstract available
   
   
   
9. SWOBODA DM, Kanagal-Shamanna R, Brunner AM, Cluzeau T, et al
   Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts.
   Leukemia. 2022;36:1189-1192.
   PubMed    
   
   
   January 2022
10. LIN Q, Lian J, Wu J, Meng P, et al
    Erythropoietin receptor contributes to thrombopoietin receptor (Mpl)-independent thrombocytopoiesis in zebrafish.
    Leukemia. 2022 Jan 18. pii: 10.1038/s41375-021-01495.
    PubMed    
    
    
    October 2021
11. ZHOU C, Kuang M, Liu Z, Jia X, et al
    Insufficiency of FZR1 disturbs HSC quiescence by inhibiting ubiquitin-dependent degradation of RUNX1 in aplastic anemia.
    Leukemia. 2021 Oct 11. pii: 10.1038/s41375-021-01445.
    PubMed     Abstract available
    
    
    September 2021
12. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 Sep 2. pii: 10.1038/s41375-021-01396.
    PubMed    
    
    
    August 2021
13. FEURSTEIN S, Churpek JE, Walsh T, Keel S, et al
    Germline variants drive myelodysplastic syndrome in young adults.
    Leukemia. 2021;35:2439-2444.
    PubMed    
    
    
    
14. GURNARI C, Pagliuca S, Patel BJ, Awada H, et al
    Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.
    Leukemia. 2021;35:2431-2434.
    PubMed    
    
    
    June 2021
15. GURNARI C, Durrani J, Pagliuca S, Kishtagari A, et al
    Novel invariant features of Good syndrome.
    Leukemia. 2021;35:1792-1796.
    PubMed    
    
    
    May 2021
16. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 May 20. pii: 10.1038/s41375-021-01261.
    PubMed     Abstract available
    
    
    April 2021
17. YOROIDAKA T, Hosokawa K, Imi T, Mizumaki H, et al
    Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia.
    Leukemia. 2021 Apr 6. pii: 10.1038/s41375-021-01202.
    PubMed     Abstract available
    
    
    
18. ZHANG L, Chen JY, Kerr C, Cobb BA, et al
    Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria.
    Leukemia. 2021;35:1176-1187.
    PubMed     Abstract available
    
    
    March 2021
19. LUNDGREN S, Keranen MAI, Kankainen M, Huuhtanen J, et al
    Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.
    Leukemia. 2021 Mar 30. pii: 10.1038/s41375-021-01231.
    PubMed     Abstract available
    
    
    
20. SEYFRIED AN, McCabe A, Smith JNP, Calvi LM, et al
    CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia.
    Leukemia. 2021 Mar 20. pii: 10.1038/s41375-021-01219.
    PubMed     Abstract available
    
    
    
21. FATTIZZO B, Ireland R, Dunlop A, Yallop D, et al
    Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.
    Leukemia. 2021 Mar 4. pii: 10.1038/s41375-021-01190.
    PubMed     Abstract available
    
    
    November 2020
22. SPORTOLETTI P, Sorcini D, Guzman AG, Reyes JM, et al
    Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.
    Leukemia. 2020 Nov 6. pii: 10.1038/s41375-020-01075.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: